You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2024

Hetero Labs Ltd V Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for HETERO LABS LTD V, and what generic and branded alternatives to HETERO LABS LTD V drugs are available?

HETERO LABS LTD V has seventy-two approved drugs.

There are four tentative approvals on HETERO LABS LTD V drugs.

Summary for Hetero Labs Ltd V
US Patents:0
Tradenames:66
Ingredients:65
NDAs:72

Drugs and US Patents for Hetero Labs Ltd V

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Exclusivity Expiration
Hetero Labs Ltd V APIXABAN apixaban TABLET;ORAL 210066-001 Nov 21, 2023 AB RX No No ⤷  Subscribe ⤷  Subscribe
Hetero Labs Ltd V SILODOSIN silodosin CAPSULE;ORAL 204793-002 Feb 14, 2020 AB RX No No ⤷  Subscribe ⤷  Subscribe
Hetero Labs Ltd V SILODOSIN silodosin CAPSULE;ORAL 204793-001 Feb 14, 2020 AB RX No No ⤷  Subscribe ⤷  Subscribe
Hetero Labs Ltd V VALSARTAN valsartan TABLET;ORAL 203311-001 Jan 5, 2015 AB RX No No ⤷  Subscribe ⤷  Subscribe
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Exclusivity Expiration
Showing 1 to 4 of 4 entries
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.